Company Name: |
Nanjing Tengyi Biotechnology Co., Ltd
|
Tel: |
025-58851786 17714337195 |
Email: |
sales@tybiochem.com |
Products Intro: |
Product Name:1H-Isoindol-1-one,2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)- CAS:133737-48-1 Purity:95+% Package:1g;5g
|
Company Name: |
Cayman Chemical Company
|
Tel: |
(800) 364-9897 |
Email: |
cayman@caymanchem.com |
Products Intro: |
Product Name:Pagoclone CAS:133737-48-1
|
|
| Pagoclone Basic information |
Product Name: | Pagoclone | Synonyms: | PAGOCLONE;1H-Isoindol-1-one, 2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-;2-(7-Chloro-2-naphthyridin-1,8-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one;Pagoclone Labeled d4;2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone;rac-Pagoclone | CAS: | 133737-48-1 | MF: | C23H22ClN3O2 | MW: | 407.89 | EINECS: | | Product Categories: | | Mol File: | 133737-48-1.mol | |
| Pagoclone Chemical Properties |
Melting point | 173-179°C | storage temp. | -20°C Freezer | solubility | DMSO (Slightly), Methanol (Slightly) | form | Solid | color | Pale Orange to Pale Red |
| Pagoclone Usage And Synthesis |
Description | Pagoclone is a new cyclopyrrolone partial agonist. In animal models of antianxiety activity, pagoclone is more potent than benzodiazepines, is less sedating, and has a high therapeutic index (Table 29–1). In clinical studies, pagoclone is well tolerated and does not appear to cause sedation or affect psychomotor or cognitive performance. In studies of volunteers, it has been shown that it does not cause withdrawal symptoms on abrupt discontinuation after 14 days. These factors all suggest that pagoclone may be an important drug for the future. It is currently entering dose-ranging and comparative studies involving patients with anxiety disorders, and in a pilot crossover study, it reduced panic attacks; adverse effects were not different from or more numerous than those reported with placebo (Sandford et al. 1998). | Uses | Pagoclone is a partial GABAA agonist, used to reduce panic attacks and appear to decrease symptoms of generalized anxiety. | Uses | Anti-anxiety agent. | Brand name | Bextra (Interneuron). | Side effects | Pagoclone is a novel cyclopyrrolone that acts as a partial GABAA receptor agonist. Preclinical studies suggest that pagoclone may have clinical utility as an anxiolytic agent, as well as a reduced incidence of side-effects. Pagoclone differs from benzodiazepines in that it does not emit a full electrophysiological response to GABA stimulation in vitro. Adverse events appear to be dose-related, with the most common side-effects reported as somnolence, dizziness, headache, asthenia, and lethargy, though cognitive effects have not yet been tested. |
| Pagoclone Preparation Products And Raw materials |
|